Correlation Between Acumen Pharmaceuticals and Cintas

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Cintas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Cintas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Cintas, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Cintas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Cintas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Cintas.

Diversification Opportunities for Acumen Pharmaceuticals and Cintas

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Acumen and Cintas is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Cintas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cintas and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Cintas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cintas has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Cintas go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Cintas

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Cintas. In addition to that, Acumen Pharmaceuticals is 4.43 times more volatile than Cintas. It trades about -0.02 of its total potential returns per unit of risk. Cintas is currently generating about 0.1 per unit of volatility. If you would invest  10,774  in Cintas on October 27, 2024 and sell it today you would earn a total of  8,965  from holding Cintas or generate 83.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Cintas

 Performance 
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Cintas 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cintas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cintas is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Acumen Pharmaceuticals and Cintas Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acumen Pharmaceuticals and Cintas

The main advantage of trading using opposite Acumen Pharmaceuticals and Cintas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Cintas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cintas will offset losses from the drop in Cintas' long position.
The idea behind Acumen Pharmaceuticals and Cintas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities